These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 19273123

  • 1. Current strategies for the inhibition of hepatic glucose production in type 2 diabetes.
    Edgerton DS, Johnson KM, Cherrington AD.
    Front Biosci (Landmark Ed); 2009 Jan 01; 14(3):1169-81. PubMed ID: 19273123
    [Abstract] [Full Text] [Related]

  • 2. Metabolic Effects of Metformin in Humans.
    Adeva-Andany MM, Rañal-Muíño E, Fernández-Fernández C, Pazos-García C, Vila-Altesor M.
    Curr Diabetes Rev; 2019 Jan 01; 15(4):328-339. PubMed ID: 30306875
    [Abstract] [Full Text] [Related]

  • 3. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ, McGill MA.
    Clin Drug Investig; 2012 Jan 01; 32(1):1-14. PubMed ID: 27933595
    [Abstract] [Full Text] [Related]

  • 4. The entero-insular axis: implications for human metabolism.
    Ranganath LR.
    Clin Chem Lab Med; 2008 Jan 01; 46(1):43-56. PubMed ID: 18020966
    [Abstract] [Full Text] [Related]

  • 5. Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes.
    Cravalho CKL, Meyers AG, Mabundo LS, Courville A, Yang S, Cai H, Dai Y, Walter M, Walter PJ, Sharma S, Chacko S, Cogen F, Magge SN, Haymond MW, Chung ST.
    Diabetologia; 2020 Oct 01; 63(10):2194-2204. PubMed ID: 32728891
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
    Meece J.
    Curr Med Res Opin; 2007 Apr 01; 23(4):933-44. PubMed ID: 17407650
    [Abstract] [Full Text] [Related]

  • 7. The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact.
    Phielix E, Szendroedi J, Roden M.
    Trends Pharmacol Sci; 2011 Oct 01; 32(10):607-16. PubMed ID: 21824668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy.
    König M, Holzhütter HG.
    J Biol Chem; 2012 Oct 26; 287(44):36978-89. PubMed ID: 22977253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.